Radius VSM and Accessories
Masimo Corporation · Decision date Oct 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 14 October 2026 for K260676, submitted by Masimo Corporation of Irvine, California, covering the device named Radius VSM and Accessories. The application was received on 2 March 2026 and listed as a Traditional 510(k) reviewed by FDA rather than a third party; it was not recorded as a combination product, and no predetermined change control plan was authorized. SESE in this 510(k) context denotes clearance, not PMA approval.
The record classifies the device under regulation 870.1025 as a physiological patient monitor with arrhythmia detection or alarms, with primary product code MHX and subsequent codes including BZQ, DPS, DPZ, DQA, DQK, DRT, DSI, DSJ, DXN, DXQ, FLL and KMI. The regulation medical specialty and review panel are both Cardiovascular. The source does not include the indications for use, the components or accessories covered, performance data, or the predicate device, so the basis for the equivalence determination remains unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260676
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Masimo Corporation
- Product code
- MHX
- Decision code
- SESE
- Decision date
- Oct 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms).
- Applicant
- Masimo Corporation
- Product code
- MHX
- FDA device class
- 2
FDA decision timeline
K260676 received
Application receipt date recorded by FDA.
K260676 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MHX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
12SL PrecisionK261307 | Ge Medical Systems Information Technologies, Inc. | 510(k) clearance | Nov 3, 2026 | FDA |
| GE Healthcare Finland Oy | 510(k) clearance | Sep 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Masimo Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Irvine, CA
Sources and methodology
- Original FDA record: K260676
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
